Anti-tumor necrosis factor therapy and influenza: Keeping it in perspective

  • Matt Shale
  • , Markus Czub
  • , Gilaad G. Kaplan
  • , Remo Panaccione
  • , Subrata Ghosh

Research output: Contribution to journalReview articlepeer-review

Abstract

The association of opportunistic infections in the context of anti-tumor necrosis factor (TNF) antibody therapies have attracted widespread attention. The recent H1N1 influenza pandemic brought this into sharp focus with numerous patient queries and physician anxieties. The following short review gives a scientific perspective to this issue including the role of vaccination.

Original languageEnglish
Pages (from-to)173-177
Number of pages5
JournalTherapeutic Advances in Gastroenterology
Volume3
Issue number3
DOIs
Publication statusPublished - May 2010
Externally publishedYes

Keywords

  • Anti-tumor necrosis factor antibody
  • Inflammatory bowel disease
  • Influenza
  • Vaccine

Fingerprint

Dive into the research topics of 'Anti-tumor necrosis factor therapy and influenza: Keeping it in perspective'. Together they form a unique fingerprint.

Cite this